Table 3.
Periostin | MTT absorbance at 570 nm | Membrane | Mean±SD | P |
---|---|---|---|---|
Cells not treated with periostin | Day 2 | ACS | 0.06±0.004 | <0.001 |
NcHC | 0.01±0.006 | |||
Day 5 | ACS | 0.08±0.008 | 0.001 | |
NcHC | 0.02±0.008 | |||
Day 7 | ACS | 0.10±0.009 | 0.001 | |
NcHC | 0.04±0.006 | |||
Cells treated with periostin | Day 2 | ACS | 0.07±0.005 | 0.001 |
NcHC | 0.01±0.009 | |||
Day 5 | ACS | 0.11±0.009 | <0.001 | |
NcHC | 0.02±0.009 | |||
Day 7 | ACS | 0.15±0.008 | <0.001 | |
NcHC | 0.05±0.006 |
P≤0.05% is considered significant. MTT – 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; ACS – Absorbable Collagen Sponge; NcHC – Nanocrystalline hydroxyapatite collagen; SD – Standard deviation; P – Probability